Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000195234 | SCV000246547 | uncertain significance | not specified | 2015-01-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001311753 | SCV001502052 | likely benign | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001311753 | SCV001850615 | benign | not provided | 2021-05-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001311753 | SCV002203548 | likely benign | not provided | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381650 | SCV002689640 | likely benign | Inborn genetic diseases | 2018-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004541234 | SCV004788050 | likely benign | ARID1B-related disorder | 2021-05-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |